BOCA RATON, Fla.--(BUSINESS WIRE)--Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis(MS), has today announced that its wholly owned subsidiary, Designer Diagnostics, Inc., will be featured in an upcoming article published in the International Journal of TB and Lung Diseases. The article, which is authored by leading NonTuberculous Mycobacterium (NTM) research scientist, Dr. Rahul Narang, will cover Designer Diagnostics’ paraffin culture technology to isolate NTM.
